Impact of a community liver pathway on referrals to secondary care liver services: a natural experiment using controlled interrupted time-series analysis
Impact of a community liver pathway on referrals to secondary care liver services: a natural experiment using controlled interrupted time-series analysis
Objective: to evaluate the impact of the Southampton Liver Pathway (SLP), a community-based liver disease detection programme, on hospital hepatology referrals.
Method: the SLP was implemented in Southampton City Clinical Commissioning Groups (SCCG) in January 2018. At-risk patients underwent enhanced liver fibrosis testing, with those scoring >9 referred for community-based FibroScan. Patients with liver stiffness >10 kPa were recommended for secondary care referral. A controlled interrupted time-series (CITS) design was used to compare monthly hepatology referral rates in SCCG before and after implementation with those in a control region (West Hampshire Clinical Commissioning Group, WHCCG) where no pathway existed. Potential system-level confounders were assessed by analysing trends in non-hepatology referrals and fibrosis testing volumes.
Results: following implementation, 1654 new hepatology referrals were made from SCCG over 19 months (median 37/month, range 25–57), compared with 44/month pre-SLP (range 30–64). In WHCCG, referrals remained stable (median 28/month, range 20–41 pre-SLP, 14–34 post-SLP). CITS analysis showed a significant reduction in hepatology referrals in SCCG after the SLP was introduced compared with both the control region (incidence rate ratio, IRR 0.95, 95% CI 0.93 to 0.98, p=0.001) and the preimplementation period (IRR 0.97, 95% CI 0.95 to 0.98, p<0.001). This reduction was not explained by system-level confounders: non-hepatology referrals increased and primary care fibrosis testing rose postimplementation.
Conclusions: the introduction of a structured primary care liver disease pathway was associated with a significant reduction in secondary care hepatology referrals. These findings suggest that such community-based pathways may alleviate hospital pressures, even as liver disease detection activity increases.
LIVER
Smith, Alexander
7da7147a-57dd-4bba-938a-808576dc2d85
Thayakaran, Rasiah
aa19a401-3b16-4d95-8f12-69135c43302d
Parkes, Julie
59dc6de3-4018-415e-bb99-13552f97e984
Patel, Janisha
b3f5e48c-b24f-4480-b1e4-5e726a4e78c5
Buchanan, Ryan
9499f713-f684-4046-be29-83cd9d6f834d
Smith, Alexander
7da7147a-57dd-4bba-938a-808576dc2d85
Thayakaran, Rasiah
aa19a401-3b16-4d95-8f12-69135c43302d
Parkes, Julie
59dc6de3-4018-415e-bb99-13552f97e984
Patel, Janisha
b3f5e48c-b24f-4480-b1e4-5e726a4e78c5
Buchanan, Ryan
9499f713-f684-4046-be29-83cd9d6f834d
Smith, Alexander, Thayakaran, Rasiah, Parkes, Julie, Glyn-Owen, Kate, Patel, Janisha and Buchanan, Ryan
(2025)
Impact of a community liver pathway on referrals to secondary care liver services: a natural experiment using controlled interrupted time-series analysis.
Frontline Gastroenterology, [flgastro-2025-103286].
(doi:10.1136/flgastro-2025-103286).
Abstract
Objective: to evaluate the impact of the Southampton Liver Pathway (SLP), a community-based liver disease detection programme, on hospital hepatology referrals.
Method: the SLP was implemented in Southampton City Clinical Commissioning Groups (SCCG) in January 2018. At-risk patients underwent enhanced liver fibrosis testing, with those scoring >9 referred for community-based FibroScan. Patients with liver stiffness >10 kPa were recommended for secondary care referral. A controlled interrupted time-series (CITS) design was used to compare monthly hepatology referral rates in SCCG before and after implementation with those in a control region (West Hampshire Clinical Commissioning Group, WHCCG) where no pathway existed. Potential system-level confounders were assessed by analysing trends in non-hepatology referrals and fibrosis testing volumes.
Results: following implementation, 1654 new hepatology referrals were made from SCCG over 19 months (median 37/month, range 25–57), compared with 44/month pre-SLP (range 30–64). In WHCCG, referrals remained stable (median 28/month, range 20–41 pre-SLP, 14–34 post-SLP). CITS analysis showed a significant reduction in hepatology referrals in SCCG after the SLP was introduced compared with both the control region (incidence rate ratio, IRR 0.95, 95% CI 0.93 to 0.98, p=0.001) and the preimplementation period (IRR 0.97, 95% CI 0.95 to 0.98, p<0.001). This reduction was not explained by system-level confounders: non-hepatology referrals increased and primary care fibrosis testing rose postimplementation.
Conclusions: the introduction of a structured primary care liver disease pathway was associated with a significant reduction in secondary care hepatology referrals. These findings suggest that such community-based pathways may alleviate hospital pressures, even as liver disease detection activity increases.
Text
Smith_Manuscript_FG_2.1.CLEAN
- Accepted Manuscript
More information
e-pub ahead of print date: 18 September 2025
Keywords:
LIVER
Identifiers
Local EPrints ID: 506835
URI: http://eprints.soton.ac.uk/id/eprint/506835
ISSN: 2041-4137
PURE UUID: 4aaafc76-88ad-4f94-8908-4d1ecb0eaf22
Catalogue record
Date deposited: 18 Nov 2025 18:17
Last modified: 25 Nov 2025 03:05
Export record
Altmetrics
Contributors
Author:
Alexander Smith
Author:
Rasiah Thayakaran
Author:
Kate Glyn-Owen
Author:
Janisha Patel
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics